Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients

被引：0
|
作者：
Ko, J. J. [1 ]
Gelowitz, G. [1 ]
Tinker, A. V. [2 ]
Holloway, C. [3 ]
Kumar, A. [4 ]
机构：
[1] Abbotsford Reg Hosp & Canc Ctr, System Therapy, Abbotsford, BC, Canada
[2] BC Canc Agcy Vancouver, System Therapy, Vancouver, BC, Canada
[3] BC Canc Agcy Victoria, Radiat Oncol, Victoria, BC, Canada
[4] Fraser Valley Canc Ctr, Syst Therapy, Surrey, BC, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
976P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients
    Tong, Nora
    Kumar, Aalok
    Gelowitz, Gerald
    Tinker, Anna
    Holloway, Caroline
    Ko, Jenny
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] The impact of adjuvant therapy on survival in patients with FIGO Stage IB Grade 3 endometrial cancer
    Garg, G.
    Ali-Fehmi, R.
    Morris, R. T.
    Schwartz, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (03) : 422 - 429
  • [3] Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study
    Akgor, Utku
    Basaran, Derman
    Meydanli, Mehmet Mutlu
    Kuscu, Esra
    Demirkiran, Fuat
    Topuz, Samet
    Sanci, Muzaffer
    Akbayir, Ozgur
    Gultekin, Murat
    Salihoglu, Mehmet Yavuz
    Akilli, Huseyin
    Bese, Tugan
    Firat, Zeliha
    Sozen, Hamdullah
    Ozgul, Nejat
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [4] Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer
    Akgor, Utku
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (03)
  • [5] Survival Analysis of FIGO Stage IIIC Endometrial Cancer Patients
    Brown, A. P.
    Gaffney, D. K.
    Dodson, M. K.
    Soisson, A. P.
    Sause, W. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S145 - S145
  • [6] Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer
    Lum, Marija M.
    Belnap, Thomas W.
    Frandsen, Jonathan
    Brown, Aaron P.
    Sause, William T.
    Soisson, Andrew P.
    Dodson, Mark K.
    Werner, Theresa
    Gaffney, David K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03): : 283 - 288
  • [7] Optimal Adjuvant Management for FIGO Stage III Endometrial Cancer: Is Timing Everything?
    Goodman, C. R.
    Seagle, B. L. L.
    Donnelly, E. D.
    Shahabi, S.
    Strauss, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S222 - S223
  • [8] Clinical Outcomes Following Adjuvant Management of FIGO Stage II Endometrial Cancer
    Mohammadi, H.
    Abuodeh, Y. A.
    Naghavi, A. O.
    Fernandez, D. C.
    Montejo, M. E.
    Apte, S. M.
    Hoffman, M. S.
    Shahzad, M. M.
    Wenham, R. M.
    Chon, H. S.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E651 - E651
  • [9] Impact of FIGO 2023 staging criteria for endometrial cancer on stage migration and survival outcomes
    Lim, Justin
    Dzyubak, Oleksandra
    Moshkovich, Michal
    Chen, Shiyi
    Han, Kathy
    Hodgson, Anjelica
    Ferguson, Sarah
    Kim, Rachel Soyoun
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S316 - S317
  • [10] Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer
    Zusterzeel, P. L. M.
    Bekkers, R. L. M.
    Hendriks, J. C. M.
    Neesham, D. N.
    Rome, R. M.
    Quinn, M. A.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (02) : 240 - 246
12345